Preclinical Research

Progress Oncology Advancements from the Start

Flexible solutions across the preclinical timeline, indications, and drug class and an expert-driven approach to lowering clinical research and clinical trial burdens.

Choose Catalyst for Early Phase Research

Early phase research plays a crucial role in oncology clinical research. Preclinical and clinical development planning helps you bring forward the best emerging science to improve cancer diagnosis and treatment.

Why Choose Catalyst for Preclinical Planning?

At Catalyst Oncology, we advance oncology therapy development from the start to help identify any gaps.

Expertise

We support biotechs with our advice to assess individual issues using our access to a highly experienced panel of oncology subject matter experts, including regulatory strategy, preclinical, toxicology, biostatistics, and pharmaceutical development partners.

Cross-functional

We integrate clinical science with cross-functional data and review processes. Oncology project teams encourage collaboration to support key milestones and provide sustained and flexible knowledge.

Comprehensive

Catalyst Oncology supports biotech companies that need assistance to develop appropriate systems, procedural documentation, and records in place.

Flexible

We offer solutions across indications and drug class. Our expert-driven approach helps lower clinical trial burdens. Clinical research organization services for what you need.

Catalyst clearly demonstrated they have the expertise and connections to evaluate this scenario thoroughly. They were very easy to work with and the quality of the output we received, together with its speed, was impressive.

Discover the Catalyst Difference

Explore our flexible, comprehensive early phase research capabilities to learn how Catalyst Oncology can work with you from the start.